Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00493337Not ApplicableCompleted

A Community Pharmacist-led Intervention to Improve Adherence to Lipid-lowering Treatment

Role: collaborator

NCT00268775Not ApplicableCompleted

Implementation Strategies for a Simple Intervention to Reduce Longterm Benzodiazepine Use in Dutch Community Pharmacies

Role: collaborator

NCT00509717Not ApplicableCompleted

Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering Drugs

Role: collaborator

NCT00460343Not ApplicableCompleted

Pharmacy Implementation Trial: Adherence to Antihypertensive Therapy

Role: collaborator

All 4 trials loaded